Crohn's disease (CD) is caused by a trigger, almost certainly enteric infection by one of a multitude of organisms that allows faeces access to the tissues, at which stage the response of individuals predisposed to CD is abnormal. In CD the failure of acute inflammation results in the failure to recruit neutrophils to the inflammatory site, as a consequence of which the clearance of bacteria from the tissues is defective. The retained faecal products result in the characteristic chronic granulomatous inflammation and adaptive immune response. Impaired of digestion of bacteria and fungi by CGD neutrophils can result in a similar pathological and clinical picture. The neutrophils in CD are normal and their inadequate accumulation at sites This article is protected by copyright. All rights reserved. of inflammation generally results from diminished secretion of pro-inflammatory cytokines by macrophages consequent upon disordered vesicle trafficking.
. The immunopathogenesis of CD occurs in three temporally distinct stages.
Penetration of luminal contents into underlying tissues occurs in stage 1, which may be facilitated by environmental factors such as infection, or inherent defects in the mucosal barrier. In healthy individuals, resident macrophages secrete pro-inflammatory cytokines in response to this material, resulting in neutrophil accumulation, clearance of the material, and thereby resolution. In CD patients, defective secretion of pro-inflammatory cytokines by macrophages results in impaired neutrophil influx and impaired clearance of foreign material (stage 2). Subsequently, chronic inflammatory responses (stage 3) will be triggered, giving rise to the characteristic features of the CD lesion. From 6 Figure 1 
Phase 1: The trigger -The infectious environmental factor
Infection has long been considered to cause CD. In the first description by Danziel in 1913 of what was later to be called Crohn's disease, the similarity between "chronic interstitial enteritis" and Johne's disease in cattle 7 , which is caused by infection with Mycobacterium avium paratuberculosis, was commented upon 8 .
There is strong epidemiological evidence for the role of an infectious environmental factor in the pathogenesis of CD. This is most obviously seen when populations or families emigrate from one country to another. Several prospective studies have followed the course of patients after infections with enteric organisms and all have found an increased incidence of IBD as compared with uninfected control subjects [9] [10] . In one of these 11 the risk was similar whether or not an infecting agent was identified, suggesting that it was the damage to the bowel rather than a specific infection that was important.
Most gastrointestinal infections do not generally produce homogeneous mucosal damage but lead to focal areas of ulceration 12, 13 , often in those regions of the bowel affected by CD.
Because infection with invasive gastrointestinal pathogens is a stochastic process 14 , the age at which this occurs is highly variable, as is the outcome after the infection. This outcome will This article is protected by copyright. All rights reserved.
depend upon the severity of the infection, extent of ulceration, quantity of bowel contents gaining access to the tissues and on the effectiveness of the innate immune response.
Individuals with a genetic predisposition to CD might not express this if their bowel mucosa is not sufficiently damaged to induce the disease. This lack of penetrance can cause confusion in genetic studies.
The age of onset peaks at between 20 and 30 years of age, which coincides with a stage in life accompanied by major lifestyle changes. These include the movement of individuals out of the family home, in which the ambient microbiome is likely to be relatively stable, into environments in which the risks of exposure to infection are much greater. The main two ways in which young adults are exposed to infectious enteric organisms is through the ingestion of contaminated food or fluids, or by person to person contact, the risk of both being increased by travel to places where exposure to novel organisms is more likely.
Although enteric infections are generally considered to be foodborne, only about one half are in fact transmitted in this way 15 , most of the rest being transferred by person to person contact. Sexual transmission is worthy of consideration as a means of transmission of faecal organisms between individuals because, as might be expected, the peak age for the acquisition of sexually transmitted diseases is very similar to that of CD.
Diet has a major influence on the gut microbiota 16 which will influence the state of inflammation or "priming" of the innate response, the adaptive response, and the reception given by the microbial flora to invasion by novel organisms.
Phase 2: A defective inflammatory response to the damaged bowel
The submucosa of the bowel is particularly vulnerable to microbial invasion. If the mucosal barrier is breached large numbers of organisms can achieve rapid access, and the conditions are conducive to microbial proliferation. There is inadequate time for adaptive immunity to take effect, and reliance must be placed on the innate system to contain and eliminate potentially harmful stimuli. At its heart this means the rapid and florid release of This article is protected by copyright. All rights reserved.
pro-inflammatory cytokines from lamina propria macrophages 17 , recruited from blood monocytes 18 , mast cells 19, 20 , eosinophils and innate lymphoid cells [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] when activated by bowel contents. Paneth cells reside in small clusters at the base of crypts of Lieberkühn in the small intestine, and they discharge antimicrobials, such as the alpha defensins, into the crypt lumen. These effector molecules also diffuse from the crypt and disseminate into the mucous layer that overlies the mucosal epithelium, where they contribute to the mucosal antimicrobial barrier 24 .
Pro-inflammatory cytokines induce changes in the microvasculature 25, 26 leading to the extravasation of plasma proteins and to the recruitment of neutrophils 27 . A critical concentration of neutrophils is required to eliminate invading bacteria 28 , and immediately after bacterial penetration of the mucosa there is direct competition between bacterial replication and neutrophil recruitment and bacterial phagocytosis, followed by killing. In the absence of specific antibodies, uptake of the foreign material is enhanced by non-specific opsonins like pentraxins, collectins and complement 29 . The neutrophils then undergo apoptosis or necrosis, and the purulent collection is most probably discharged into the bowel lumen, with the residual debris being phagocytosed and cleared by macrophages 30 .
Immunoparesis of the acute inflammatory response is the underlying Crohn's phenotype
The underlying pathology in Crohn's disease is the ineffective manner in which the faecal material entering the tissues through the damaged mucosa is dealt with. Infective damage to the mucosa followed by the entry of faecal material, with a bacterial count of greater than 10 11 bacteria per ml, into the tissues, poses an existential threat that must be dealt with vigorously. This is accomplished by the acute inflammatory response, a non-specific local reaction to tissue damage that recruits the innate immune system. It includes the secretion of inflammatory mediators from mast cells and macrophages, complement activation, markedly increased blood flow, capillary dilatation and increased permeability, the deposition This article is protected by copyright. All rights reserved. superficial abrasions on the arm, called "skin windows", was grossly deficient when compared with healthy subjects or patients with another chronic inflammatory condition, rheumatoid arthritis 31 . It was observed that "This abnormality of neutrophil function in Crohn's disease appears to be secondary to a defective acute inflammatory response, as the neutrophils themselves were found to behave normally on in-vitro testing. A weak acute inflammatory response to particulate or antigenic material in the bowel wall could result in the chronic inflammation observed in this condition."
The next in these series of experiments was conducted on the ileal and rectal mucosa, and again on the skin 32 . A small mucosal biopsy was taken from the ileum or rectum, and this was then followed 6 hours later by a further biopsy of the previous biopsy site, to determine the extent of the inflammatory response induced by the initial biopsy trauma. Once again there was a major delay in the recruitment of neutrophils in CD, and this was observed in both regions of the bowel. In addition to healthy subjects, control individuals with UC were studied, and their neutrophil recruitment was normal. Trauma to the skin reproduced the impaired neutrophil recruitment into skin windows, and the secretion of IL-8 and IL-1β from the windows was abnormally low.
The direct injection of heat killed E. coli into the subcutaneous tissues of the forearm of normal subjects is followed by profound rise in local blood flow. This was considerably impaired in CD, but not in UC. Blood flow is important in recruiting innate immune cells to sites of inflammation.
The third set of these experiments directly measured the accumulation of neutrophils at the site at which E. coli had been injected subcutaneously into human subjects, and then subsequently, the rate of clearance of these organisms. In this study peripheral blood neutrophils were purified from the individual under investigation, labelled with the gamma-ray emitting radioisotope Indium-111 33 , and reinjected intravenously at the same time that unlabelled E. coli were injected subcutaneously into the forearms. The rate of accumulation This article is protected by copyright. All rights reserved. of the radioactive neutrophils over the site of the injected bacteria was determined 34 . A much smaller proportion of neutrophils were recruited to the injected bacteria in the CD subjects than in the human controls (HC) or UC individuals ( Figure 3 ). The next step was to radiolabel the E. coli with Phosphorus-32 and to then determine the rate of clearance of the bacteria from the tissues. This was a two-phase process in HC and UC subjects with a very rapid initial clearance lasting about 4 hours followed by a slower phase, with total clearance being achieved by 7 to 10 days. In the CD subjects, initial clearance was much less efficient and total clearance was markedly delayed and was predicted to last from several weeks to infinity. This study showed unequivocally that in CD coliform bacteria are cleared much less efficiently from the tissues than normal. It might be considered that this delayed recruitment of neutrophils to bacteria in the tissues should predispose these individuals to an increased incidence of clinically evident infections, which is not an obvious manifestation of CD. The reason for this apparent discrepancy is that the numbers of bacteria injected into the tissues were required to reach a certain critical load before the clearance defect was unmasked ( Figure 3e ). In this study 10 6 organism were cleared normally whereas 10 7 were not, indicating that a significant bacterial load must enter the tissues before the clearance systems are overwhelmed. The bowel is the only location in the body where such a burden of microbes is readily available to enter the tissues.
This article is protected by copyright. All rights reserved. In the absence of an adequate acute inflammatory response and the complete clearance of the inciting agent by neutrophils, the retained foreign material produces a granulomatous inflammation [35] [36] . E. coli, Streptococci and Listeria have been demonstrated immunochemically in macrophages, giant cells and lymph nodes of CD patients 37 , and E. coli DNA has been identified in Crohn's granulomata isolated by laser capture microdissection 38 . The retention of this faecal material within the bowel leads to an intense adaptive immune response, and the tissues become infiltrated with large numbers of T-cells.
It is not therefore surprising that when actively inflamed CD tissues are biopsied, any number and variety of adaptive immune cells can be identified and immune mechanisms evoked in the pathogenesis of the condition. The macrophages and adaptive immune cells, reacting to the foreign antigenic material, will produce cytokines such as IL-1β and TNFα 39, 40 that lead to local inflammation and systemic symptoms 41 .
The clinical picture of an inflamed bowel containing large numbers of macrophages and Tcells 42, 43 has led to the erroneous belief that Crohn's was an autoimmune disease 44 . It is however clear that the cytokines produced by these inflammatory foci in their response to foreign faecal material contribute to the local and systemic inflammation, and failure of This article is protected by copyright. All rights reserved. mucosal healing, as evidenced by the, often dramatic, responses to anti-TNF drugs.
However, only about half the patients respond to this treatment, and in those that do the response is often partial and temporary 45 .
This failure to clear organic material from the tissues offers an explanation for the falsepositive Kveim tests observed in CD 46 . The Kveim test 47 was designed to diagnose sarcoidosis, another chronic granulomatous disease. The intradermal injection of a crude homogenate of an extract of sarcoid tissue, usually from lymph node, produced epithelioid cell granulomas in subjects with sarcoidosis, reproducing those diagnostic of this disorder.
Initially it was thought that the injected material contained some sarcoid specific factor, such as an infectious agent or antigen 48 but it has been recognised more recently that it relates to inefficient cellular immune processing, due most often to impaired myeloid dendritic cell function of unknown cause 49 . This is precisely the nature of the pathogenic mechanism in CD, and it is therefore not surprising that positive tests are found in both conditions 50 and that both diseases occasionally coexist in the same individual 51 .
On the location of the CD lesions
Symptomatic lesions are largely confined to the terminal ileum, caecum and colon, probably due to the combination of mucosal damage by enteric infection coupled with the ready presence of massive numbers of bacteria to penetrate into the wall of the bowel when this happens. However, it is becoming apparent that the gastrointestinal tract is generally diffusely, sub-clinically, abnormal.
Oral manifestation of CD, particularly aphthous ulcers, are estimated to occur in 20-50% of patients 52 . A prospective endoscopic study identified upper gastrointestinal (GI) manifestations of CD in 55% of 108 untreated, newly diagnosed adult patients with CD, irrespective of symptoms. About a quarter of the patients had lesions in both the stomach and duodenum and in about 20% they were in one or other of these organs. In roughly 2% of patients the gastric outlet is obstructed by a granulomatous inflammation requiring This article is protected by copyright. All rights reserved. surgical intervention 53 . Aphthous ulcers in the oesophagus were present in 7% of these subjects. Most of these lesions exhibited a granulomatous inflammation on histology.
In view of the systemic nature of the impairment of the innate immune system in CD, it is of great interest, although not altogether surprising that patients with chronic granulomatous disease (CGD) 54 exhibit very similar gastrointestinal pathology. CGD is a condition in which there is a failure of microbial killing and digestion by neutrophils as a result of excessively acid phagocytic vacuoles in which the pH is too low for the efficient activity of the neutral protease digestive enzymes which fail to kill and digest the microbes 55, 56 . Some of these cases can present early and make up about 10% of a group of children with very early onset bowel inflammation 57 .
Aphthous ulceration and other oral lesions are common in CGD. Oesophageal, gastric and duodenal inflammation were detected in 21%,74% and 37% of 78 patients 58 . Large bowel lesions were present in the majority 58 and are indistinguishable from those of CD 59, 60 .
Between 4% 61 and 15% 62 of these patients also develop gastric outflow obstruction.
Identifying the molecular cause/s of the CD phenotype
The abnormality of innate immunity in most cases of CD lies in the macrophages Defective secretion of pro-inflammatory cytokines in CD may be the explanation for the observed impairment in neutrophil recruitment 34, [63] [64] . In CD, the neutrophils themselves are normal 65 , exhibit normal migration in vitro 31, 66, 67 and will migrate out of skin windows if chemoattractant substances are placed over them 32 . In the absence of a primary abnormality of neutrophil function, CD macrophages showed defective secretion of pro-inflammatory cytokines, but normal release of chemokines, in response to stimulation with E. coli 34 (Figure   4 ). The genes for these pro-inflammatory cytokines were transcribed and translated, but the proteins were misdirected to lysosomal degradation rather than secretion, suggestive of disordered vesicle trafficking. This article is protected by copyright. All rights reserved. 
What is the molecular cause of the impairment of acute inflammation?
There is a strong genetic component to the aetiology of CD. The sibling recurrence risk (risk of developing the disease in the context of an affected sibling) is approximately 13-36% 68 , and approximately 12% 69 of CD patients have at least one affected first degree relative.
Furthermore, the study of over 300 twin pairs has demonstrated a higher concordance of disease phenotype in monozygotic (30%) compared with dizygotic twins (4%) 70 .
Technological advances have provided the means of interrogating the genetic basis of CD.
Linkage and Genome Wide Association studies (GWAS)
GWAS Increasingly large GWAS have been performed on CD and the results meta-analysed 71, 72 .
No single or small number of penetrant mutations have been found that independently cause the disease. The latest study of over 20,500 CD cases and 41,600 controls of European ancestry identified 145 loci associated with CD at p<5×10 -8 . The mean OR of the top SNPs representing these 145 loci was 1.16, and the mean control allele frequency was 0.48. Four SNPs had an OR exceeding 1.5 of which three were within NOD2 and the fourth was in IL23R. The mean difference in allele frequency between cases and controls was only 0.02. 73 
NOD2
The nucleotide-binding oligomerization domain (NOD) protein, NOD2, belonging to the intracellular NOD-like receptor family, detects conserved motifs in bacterial peptidoglycan and promotes their clearance through activation of a pro-inflammatory transcriptional program and other innate immune pathways, including autophagy and endoplasmic reticulum stress 74 .
ATG-16L1 (ATG16L1 (autophagy-related 16-like 1))
The process of autophagy influences several aspects of mucosal immune responses. Initially described as a "self-eating" survival pathway that enables nutrient recycling during starvation, autophagy has now been connected to multiple cellular responses, including several aspects of immunity. Initial links between autophagy and host immunity came from the observations that autophagy can target intracellular bacteria for degradation. However, subsequent studies indicated that autophagy plays a much broader role in immune responses, as it can impact antigen processing, thymic selection, lymphocyte homeostasis, and the regulation of immunoglobulin and cytokine secretion 75 . This article is protected by copyright. All rights reserved.
ATG16L1 interacts with NOD2. NOD2 has recently been identified as a potent autophagy inducer and a physical interaction of NOD2 and ATG16L1 appears to be required for autophagic clearance of intracellular pathogens 76 .
IL-23R
This gene codes for a subunit of the receptor for IL-23. This protein pairs with the receptor molecule IL-12Rβ1 (IL12RB1), together forming the IL-23 receptor complex, and both are required for IL-23 signalling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner.
IL-23 is pro-inflammatory 77 and the IL23R gene has been shown to protect against Crohn's disease 78 .
GWAS have been performed for many different diseases, and IBD-associated loci have been shown to be shared with several other immunologically mediated diseases including Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Ankylosing spondylitis, Coeliac disease and Sarcoidosis 79 . These associations are not surprising, as comorbidities of some of these conditions are well recognised in the context of IBD [80] [81] and because almost all are associated with an increased incidence of similar pathologies, such as arthritis 82 , uveitis 83, 84 and bowel inflammation [85] [86] .
Other investigations to identify causal molecules

Macrophage expression profiling
In the knowledge that the release of pro-inflammatory cytokines by macrophages from CD subjects is depressed as a result of impaired vesicle trafficking 34 , an attempt was made to identify genes contributing to this deficiency by looking for outlier levels of gene expression in these cells. The most commonly under-expressed genes identified were Optineurin and ADAMDEC1.
This article is protected by copyright. All rights reserved.
Optineurin (OPTN) 87,88 is a 67-kDa linker, or adaptor, molecule that is important in vesicle trafficking. It has several binding partners, including Rab8, Huntingtin, and Myosin VI, a multifunctional motor protein. OPTN plays a role in acute inflammation and neutrophil recruitment 89 . OPTN-deficient mice were more susceptible to Citrobacter colitis and E. coli peritonitis, and showed reduced levels of pro-inflammatory TNFα in their serum, diminished neutrophil recruitment to sites of acute inflammation and greater mortality, compared with wild-type mice. OPTN-knockdown zebrafish infected with Salmonella also had a higher mortality.
ADAMDEC1 (ADAM-like Decysin-1) is a member of the ADAM (A Disintegrin And
Metalloproteinase) family, the expression of which is restricted to the macrophage/dendritic cell populations of the gastrointestinal tract. Its biological function is unknown, but it has been hypothesised to play a role in immunity. Adamdec1 -/mice were more susceptible to the induction of bacterial and chemical induced colitis, and greater numbers of Citrobacter rodentium were found in the spleen, suggestive of a breakdown in mucosal immunity which resulted in bacteraemia 90 .
DNA sequencing
Several studies have focussed on the analysis of Ashkenazi Jews (AJ) because they have a roughly fourfold increased incidence of CD. Two studies, one in a population of patients with sporadic disease 91 and the other, using a family-based approach 92 , identified a frameshift mutation in CSF2RB as a strong causal candidate in a population of CD patients.. CSF2RB is the common or shared β subunit of the receptors for granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5 93 . The distinct α chains of these receptors provide cytokine specificity whilst the β chain is responsible for high-affinity binding, and is the major downstream signalling component of the receptor complexes.
Incubation of cells with GM-CSF resulted in high levels of phosphorylation of signal transducer and activator of transcription (STAT5), which was defective in cells containing the mutant CSF2RB 92 . This article is protected by copyright. All rights reserved.
GM-CSF is produced by myeloid cells, dendritic cells (DCs), T cells, B cells, and several
non-immunological cells including epithelial cells 94 following exposure to inflammatory stimuli to promote the production and function of myeloid haemopoietic cells including haemopoietic progenitor cells and differentiated cells such as basophils, neutrophils, eosinophils, macrophages and certain dendritic cells 95 to deal with the cause of the inflammation.
IL-3 is predominantly produced by activated T cells, natural killer (NK) cells and mast cells
and IL-5 stimulates mainly the production and function of eosinophils. The major source of IL-5 is T-cells with relatively lower amounts produced by mast cells and eosinophils 96 .
LRRK2 has also been associated with CD in this population of patients 97 . LRRK2 is found in immune cells, in lamina propria macrophages, B-lymphocytes, dendritic cells, and neutrophils, and levels are markedly increased in the bowel in CD 98 and in microglia in the nervous system 99 . It interacts with small GTPases including Rab32 and Rab38 with which it co-locates to transport vesicles and recycling endosomes 100 and it is important for the elimination or intracellular Salmonellae 101 and Legionella 102 . The association of variants in LRRK2 with CD is consistent with the observation of abnormal vesicle trafficking in macrophages from patients with this condition 34 . Rab32 and Rab38 play an important role in the biogenesis and traffic of melanosomes and lysosomes and this system is disordered in Hermansky-Pudlak syndrome 103 , accounting for the characteristic partial albinism. If LRRK2 and its associated proteins are important for immunological resistance to the development of CD then it might be expected that CD would be more common in conditions in which the LRRK2 system is disordered, which is in fact the case -a clear association exists between CD and Parkinson's disease, 104, 105 and CD and Hermansky-Pudlak 106 .
LRRK2 complexes with, phosphorylates and activates the NLRC4 inflammasome during host defence against Salmonella infection and LRRK2 -/mice exhibited impaired clearance of the bacteria 107 , providing further evidence that impaired inflammation predisposes to CD. This article is protected by copyright. All rights reserved.
The majority of genes identified as causal or associated with CD relate to the immune system, either directly as in the case of NOD2 and CSF2RB, or to molecules that are important for its function, like Optineurin that is involved in vesicle trafficking and cytokine secretion.
Future treatment options
Treatment of CD poses a conundrum. The logical approach to correcting the underlying problem would be to develop means of enhancing innate immunity, although no such range of drugs is currently available. It would be dangerous to attempt to do this in the presence of ongoing bowel inflammation, but it could be useful to maintain patients in remission after they had been cleared of disease by surgical resection, or through the use of nonimmunosuppressant therapies such as elemental diets 108 .
The use of GM-CSF to increase the numbers of circulating neutrophils was found to be ineffective 109 , probably because the defect in CD relates to the attraction of neutrophils into injured tissues, rather than into the circulation.
The primary pathology in most case of CD appears to affect macrophages recruited from the blood as monocytes 110 . Advances in gene editing with the CRISPR-Cas 111,112 technology make the corrective treatment of CD a real possibility in the relatively near future. Once a primary causal mutation has been identified, and validated in animal models, bone marrow could be extracted, edited and reinfused into a conditioned patient in much the same way as is being applied to gene therapy for primary immunodeficiencies 113 .
